[
  {
    "ts": null,
    "headline": "ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions",
    "summary": "ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and logistics efficiencies, positive product mix shifts, and sustained demand in both devices and masks as primary contributors to improved profitability. CEO Mick Farrell emphasized the benefits of investments in automation and U.S.-based production, stating, “Our results are a testament to the work that we",
    "url": "https://finnhub.io/api/news?id=ac273afe1507cd62579ab7628ae03c3b7fea366ffa6bddd9cd0b73d4bfaec55c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750249635,
      "headline": "ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions",
      "id": 135360118,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and logistics efficiencies, positive product mix shifts, and sustained demand in both devices and masks as primary contributors to improved profitability. CEO Mick Farrell emphasized the benefits of investments in automation and U.S.-based production, stating, “Our results are a testament to the work that we",
      "url": "https://finnhub.io/api/news?id=ac273afe1507cd62579ab7628ae03c3b7fea366ffa6bddd9cd0b73d4bfaec55c"
    }
  }
]